0.7715
Adicet Bio Inc (ACET) 最新ニュース
Adicet Bio (NASDAQ:ACET) Upgraded by HC Wainwright to Strong-Buy Rating - Defense World
Adicet Bio’s (ACET) “Buy” Rating Reiterated at HC Wainwright - Defense World
Q2 Earnings Estimate for Adicet Bio Issued By HC Wainwright - Defense World
Everest Medicines raises $200M; Epirium Bio targets $55M Series B - Endpoints News
Does Adicet Bio Inc. stock pay reliable dividendsOutperformance with explosive growth - jammulinksnews.com
Adicet Bio doses first SSc subject in second cohort of trial evaluating ADI-001 - Yahoo Finance
Adicet Bio Announces First Systemic Sclerosis (SSc) Patient Dosed in Ongoing Phase 1 Clinical Trial of ADI-001 in Autoimmune Diseases - BioSpace
What drives Adicet Bio Inc. stock priceConsistently profitable trades - Autocar Professional
Is Adicet Bio Inc. a good long term investmentDynamic growth stocks - Autocar Professional
Adicet Bio doses first systemic sclerosis patient in ADI-001 trial By Investing.com - Investing.com South Africa
Adicet Bio doses first systemic sclerosis patient in ADI-001 trial - Investing.com Australia
Adicet Bio Announces 30% Workforce Reduction Strategy - TipRanks
Adicet Bio stock rating initiated at Buy by H.C. Wainwright - Investing.com Australia
What analysts say about Adicet Bio Inc. stockPhenomenal capital appreciation - jammulinksnews.com
Adicet Bio Inc. Stock Analysis and ForecastOutstanding risk-reward balance - jammulinksnews.com
Why Block Shares Are Trading Higher By 10%; Here Are 20 Stocks Moving Premarket - Benzinga
Esophageal Cancer Clinical Trials, Companies, Therapeutic Assessment, Therapies, Treatment Algorithm, Pipeline Analysis Miltenyi Biomedicine, Adicet Bio, Velosbio, Novartis Pharmaceuticals, Sanofi, - MenaFN
What makes Adicet Bio Inc. stock price move sharplyMarket Ready Callouts - Newser
How Adicet Bio Inc. stock performs during market volatilityFree Access to Community with 300% Return - Newser
Why Adicet Bio Inc. stock attracts strong analyst attentionSmart High Yield Swing Trades - Newser
Diffuse Large B-Cell Lymphoma Clinical Trails, Companies, Therapeutic Assessment, Therapies, Treatment Algorithm, And Pipeline Analysis Miltenyi Biomedicine, Adicet Bio, Velosbio, Novartis Pharmaceu - MenaFN
Adicet Bio, Inc. (NASDAQ:ACET) Given Average Recommendation of “Moderate Buy” by Brokerages - Defense World
Adicet Bio Elects Directors and Approves Key Proposals - TipRanks
Adicet Bio, Inc. (NASDAQ:ACET) Receives Average Rating of “Moderate Buy” from Brokerages - Defense World
Squarepoint Ops LLC Purchases New Shares in Adicet Bio, Inc. (NASDAQ:ACET) - Defense World
Adicet Bio To Present At Jefferies Global Healthcare Conference; Webcast At 4:20 PM ET - Nasdaq
Northern Trust Corp Acquires 28,153 Shares of Adicet Bio, Inc. (NASDAQ:ACET) - Defense World
ACETAdicet Bio Reports First Quarter 2025 Financial Results and Provides Business Updates - Revista ADVFN
Millennium Management LLC Lowers Position in Adicet Bio, Inc. (NASDAQ:ACET) - Defense World
Adicet Bio to Participate in a Fireside Chat at the 2025 Jefferies Global Healthcare Conference - Business Wire
Adicet Bio’s SWOT analysis: gamma-delta T cell therapy stock faces pivotal year - Investing.com
Adicet Bio, Inc. (NASDAQ:ACET) Shares Sold by D. E. Shaw & Co. Inc. - Defense World
Financial Comparison: Adicet Bio (NASDAQ:ACET) & Trevena (NASDAQ:TRVN) - Defense World
大文字化:
|
ボリューム (24 時間):